593
Participants
Start Date
October 8, 2020
Primary Completion Date
May 21, 2021
Study Completion Date
May 21, 2021
Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)
Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) is derived from the plasma of individuals who recover and develop neutralizing antibodies. Participants will receive a single infusion.
Placebo
Participants will receive a single infusion of the placebo (saline).
Remdesivir
Remdesivir will be given to participants in both groups as standard of care (SOC).
Nordsjællands Hospital, Hillerød, Hillerød
3rd Dept of Medicine, Medical School, NKUA, Athens
Washington VA Medical Center, Washington D.C.
National Institutes of Health Clinical Center, Bethesda
CJW Chippenham Medical Center, Richmond
Henrico Doctors' Hospital (HCA), Richmond
FirstHealth Moore Regional Hospital, Pinehurst
Redmond Regional Medical Center, Rome
Ohio Health Research Institute, Columbus
Hennepin Healthcare Research Institute/HCMC, Minneapolis
University of Missouri, Columbia
Cox Medical Centers, Springfield
Democritus University of Thrace, Alexandroupoli
University of Texas Southwestern Medical Center, Dallas
CHRISTUS Spohn Shoreline Hospital, Corpus Christi
Hendrick Medical Center, Abilene
Saint Anthony North Health Campus, Westminster
St. Anthony Hospital, Lakewood
Penrose Hospital, Colorado Springs
St. Francis Health Services, Colorado Springs
University of Massachusetts, Worcester
Aarhus Universitetshospital, Skejby, Aarhus
Bispebjerg Hospital, Copenhagen
CHIP, Department of Infectious Diseases, Section 2100, Copenhagen
Herlev-Gentofte Hospital, Hellerup
Hvidovre University Hospital, Department of Infectious Diseases, Hvidovre
Kolding Sygehus, Kolding
Odense University Hospital, Odense
1st Respiratory Medicine Dept, Athens University Medical School, Athens
Attikon University General Hospital, Athens
Dept. of Critical Care & Pulmonary Medicine, Evangelismos General Hospital, Athens
NCGM, Tokyo
Fujita Health University Hospital, Toyoake
Institute of Human Virology-Nigeria (IHVN), Abuja
Royal Free Hospital, London
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital del Mar, Barcelona
Hospital Clínic de Barcelona, Barcelona
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
National Institutes of Health (NIH)
NIH
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
NETWORK
University of Minnesota
OTHER